BioCentury
ARTICLE | Company News

BioPro, Ranbaxy sales and marketing update

December 8, 2008 8:00 AM UTC

BioPro granted Ranbaxy exclusive rights to market Gliadel Wafer carmustine implant in India to treat newly diagnosed high-grade glioma and recurrent glioblastoma multiforme (GBM). BioPro has rights t...